# Health X Platform (NSE: HEALTHX) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/HEALTHX · Pivot · prices to 22 Oct 2026

Health X Platform (NSE: HEALTHX) closed at ₹268.85 on 22 Oct 2026, down 0.50% on the day. With a market capitalisation of ₹855 Cr, it ranks 1534th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Pharmaceutical Retailers.

Its return on equity was −13.6% in FY25. Over the past year the share price has fallen 14.9%. Its 52-week range is ₹252.50 (30 Mar 2026) to ₹363.00 (13 Jan 2026); the last close is 25.9% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹374 Cr (+30.8% year on year) and net profit −₹13 Cr (−173.8%), on a consolidated basis. Promoters held 74.07% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹268.85 |
| Market cap | ₹855 Cr |
| ROE | −13.6% (FY25) |
| ROCE | −0.2% (FY25) |
| Debt to equity | 0 |
| 52-week high | ₹363.00 (13 Jan 2026) |
| 52-week low | ₹252.50 (30 Mar 2026) |
| 1-year return | −14.9% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹374 Cr | +30.8% | −₹13 Cr | −173.8% | −₹3.51 |
| Q3 FY26 | ₹346 Cr | +22.9% | ₹0 Cr | — | ₹0.35 |
| Q2 FY26 | ₹301 Cr | +10.2% | −₹15 Cr | — | −₹3.99 |
| Q1 FY26 | ₹298 Cr | +10.4% | ₹27 Cr | −46.8% | ₹7.52 |
| Q4 FY25 | ₹286 Cr | −6.8% | ₹18 Cr | −48.7% | ₹4.30 |
| Q3 FY25 | ₹281 Cr | −24.9% | −₹40 Cr | −298.3% | −₹8.47 |
| Q2 FY25 | ₹274 Cr | −23.7% | −₹151 Cr | −1,251.6% | −₹34.40 |
| Q1 FY25 | ₹270 Cr | −19.6% | ₹50 Cr | — | ₹9.79 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹1,111 Cr | −₹123 Cr |
| FY24 | ₹1,376 Cr | ₹92 Cr |
| FY23 | ₹1,040 Cr | −₹15 Cr |
| FY22 | ₹631 Cr | ₹984 Cr |
| FY21 | ₹548 Cr | −₹17 Cr |
| FY20 | ₹385 Cr | −₹52 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 74.07%
- Foreign institutions: 2.29%
- Domestic institutions: 2.60%
- Non-institutions: 21.04%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Wealth First Portfolio Managers](https://app.pivotnow.in/stock/WEALTH) | ₹833.10 | ₹888 Cr | 23 | — |
| [Finkurve Financial Services](https://app.pivotnow.in/stock/FINKURVE) | ₹63.00 | ₹883 Cr | 33.9 | — |
| [Hexa Tradex](https://app.pivotnow.in/stock/HEXATRADEX) | ₹156.99 | ₹867 Cr | — | — |
| [Sobhagya Mercan](https://app.pivotnow.in/stock/SOBME) | — | ₹864 Cr | — | — |
| [IIRM Holdings](https://app.pivotnow.in/stock/IIRM) | — | ₹856 Cr | — | — |
| [Max India](https://app.pivotnow.in/stock/MAXIND) | ₹151.00 | ₹849 Cr | — | — |

## Questions and answers

### What is the share price of Health X Platform today?

Health X Platform (NSE: HEALTHX) last closed at ₹268.85 on 22 Oct 2026. Its 52-week high is ₹363.00 and its 52-week low is ₹252.50.

### What is the market cap of Health X Platform?

Health X Platform's market capitalisation is ₹855 Cr (₹855 Cr) at the 22 Oct 2026 close, ranking 1534th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Health X Platform?

Return on equity was −13.6% in FY25 and return on capital employed was −0.2% in FY25 (consolidated figures).

### What were Health X Platform's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Health X Platform reported revenue of ₹374 Cr, +30.8% year on year, and net profit of −₹13 Cr, −173.8% year on year.

### How has Health X Platform stock performed over the last year?

Health X Platform's share price has fallen 14.9% over the past year, −16.5% over three months and −9.2% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Health X Platform?

As of 30 Jun 2026: promoters 74.07%, foreign institutions 2.29%, domestic institutions 2.60%, non-institutions 21.04%.

### Who are Health X Platform's competitors?

The listed Financials companies closest to Health X Platform by market cap are Wealth First Portfolio Managers, Finkurve Financial Services, Hexa Tradex, Sobhagya Mercan, IIRM Holdings and Max India.

### Is Health X Platform a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Health X Platform's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on HEALTHX against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.